IMMUNE PROFILING TO INVESTIGATE IMPROVED SURVIVAL IN PATIENTS WITH METASTATIC TRIPLE-NEGATIVE BREAST CANCER RECEIVING TRILACICLIB PRIOR TO CHEMOTHERAPY

被引：1
|
作者：
Stevens, Aaron [1 ]
O'Shaughnessy, Joyce [2 ]
Cao, Subing [1 ]
Sorrentino, Jessica [1 ]
Horton, Janet [1 ]
Yi, John [1 ]
Tan, Antoinette [3 ]
机构：
[1] G1 Therapeutics Inc, Res Triangle Pk, NC USA
[2] Baylor Univ, Med Ctr, Texas Oncol Dallas, US Oncol Res, Dallas, TX USA
[3] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.339
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
339
引用
收藏
页码：A365 / A365
页数：1
相关论文
共 50 条
  • [21] Monitoring of circulating tumor DNA in metastatic triple-negative breast cancer patients undergoing chemotherapy
    Madic, Jordan
    Kiialainen, Anna
    Bidard, Francois-Clement
    Birzele, Fabian
    Ramey, Guillemette
    Vinolo, Emilie
    Leroy, Quentin
    Rio-Frio, Thomas
    Bernard, Virginia
    Lermine, Alban
    Clausen, Inga
    Giroud, Nicolas
    Schmucki, Roland
    Horn, Carsten
    Spleiss, Olivia
    Lantz, Olivier
    Stern, Marc-Henri
    Pierga, Jean-Yves
    Weisser, Martin
    Lebofsky, Ronald
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] Atezolizumab for metastatic triple-negative breast cancer
    Stirrups, Robert
    LANCET ONCOLOGY, 2018, 19 (10): : E519 - E519
  • [23] Iniparib in Metastatic Triple-Negative Breast Cancer
    Domagala, Pawel
    Lubinski, Jan
    Domagala, Wenancjusz
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (18): : 1780 - 1780
  • [24] Treatment of Metastatic Triple-Negative Breast Cancer
    Glendenning, Jennifer
    Irshad, Sheeba
    Tutt, Andrew
    CURRENT BREAST CANCER REPORTS, 2012, 4 (01) : 10 - 21
  • [25] Treatment of Metastatic Triple-Negative Breast Cancer
    Jennifer Glendenning
    Sheeba Irshad
    Andrew Tutt
    Current Breast Cancer Reports, 2012, 4 (1) : 10 - 21
  • [26] Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer
    Michel, Laura L.
    von Au, Alexandra
    Mavratzas, Athanasios
    Smetanay, Katharina
    Schuetz, Florian
    Schneeweiss, Andreas
    TARGETED ONCOLOGY, 2020, 15 (04) : 415 - 428
  • [27] Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer
    Laura L. Michel
    Alexandra von Au
    Athanasios Mavratzas
    Katharina Smetanay
    Florian Schütz
    Andreas Schneeweiss
    Targeted Oncology, 2020, 15 : 415 - 428
  • [28] Trilaciclib improves overall survival when given with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: Final analysis of a randomized phase 2 trial
    O'Shaughnessy, Joyce
    Wright, Gail S.
    Thummala, Anu R.
    Danso, Michael A.
    Popovic, Lazar
    Pluard, Timothy J.
    Han, Hyo S.
    Vojnovic, Zeljko
    Vasev, Nikola
    Ma, Ling
    Richards, Donald A.
    Wilks, Sharon T.
    Milenkovic, Dusan
    Xiao, Jie
    Sorrentino, Jessica A.
    Horton, Janet
    Tan, Antoinette R.
    CANCER RESEARCH, 2021, 81 (04)
  • [29] Single cell transcriptomics of the immune cells during chemotherapy in triple-negative breast cancer patients
    Frolova, A.
    Gerashchenko, T. S.
    Patysheva, M.
    Fedorov, A. A.
    Bragina, O.
    Garbukov, E.
    Cherdyntseva, N.
    Korobeynikov, V. Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S194 - S194
  • [30] Dose dense neoadjuvant and adjuvant chemotherapy in triple-negative breast cancer patients: Survival analysis
    Kr, A.
    ANNALS OF ONCOLOGY, 2019, 30
12345